medigraphic.com

2016, Number 4

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2016; 54 (4)

Evolution of the Type 2 Diabetes Mellitus epidemia in insured population at the IMSS

Velasco-Contreras ME

Language: Spanish
References: 37
Page: 490-503
PDF size: 239.13 Kb.


ABSTRACT

Background: The global increase in type 2 diabetes mellitus (T2DM) is requiering higher demands in health institutions; It is a global emergency because of overspending that threaten social security, and kidney complications and cardiovascular damage, which affects millions enfermos.1 The aim of this work is to characterize the epidemic of T2DM with metabolic syndrome and defi ne the institutional response containment-control universal educational interventions healthy lifestyles to prevent premature death and disability from ischemic heart disease (IHD), cerebrovascular disease (CVD), end stage renal disease ( IRT), blindness and amputations.
Methods: A review of the years 1990-2013: Epidemiological Bulletin; consultation services: Family Medicine, Specialties, Emergency, Hospitalization, and prevention studies estimate of expenditure and institutional savings.
Results: 48 % increase incidence, prevalence increased from 7 to 10.6 %, and mortality from 35.6 to 77.2 per 100 000 inhabitants. Hypertension, and deaths, and EVC CI, increased 58, 197, 142.5 % respectively. Consultations in 2013 were 9113 082. The estimate of expenditure for prediabetes screening and medical care to prevent complications saves near of 60 % of current expenditure.
Conclusions: control the epidemic by training patients, families and staff health healthy lifestyle is the treatment to revert to normal BMI, glucose, triglycerides, HDL cholesterol, LDL cholesterol, blood pressure and addictions to snuff / alcohol, to decelerate complications of the metabolic syndrome.


REFERENCES

  1. Report of World Health Organization and International Diabetes Federation meeting: Screening for type 2 Diabetes, World Health Organitation Department of Noncommunicable Disease Management, Geneva 2013.

  2. Proyecto de Fortalecimiento de la Atención Integral de Enfermedades Crónicas en UMF; DPM, IMSS; julio de 2014.

  3. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988- 1994. Diabetes Care 1998;28:518-24.

  4. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantifi cation of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42: 1663-1672.

  5. Gordon C. Weir and Susan Bonner-Weir. Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes. Diabetes December 2004 vol. 53 no. suppl 3 S16-S21.

  6. Reaven GM The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006;83:1237-1247 7.Sattar N1, McConnachie A, Shaper; Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008 Jun 7;371(9628):1927-35.

  7. Festa A, Williams K, D’Agostino R Jr, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 2006;55:1114.

  8. Nesto RW1.Gordon C. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome Am J Cardiovasc Drugs. 2005;5(6):379-87.

  9. Keiichi Kodama, MD, PHD1, Damon Tojjar, MD. Ethnic Differences in the Relationship Between Insulin Sensitivity and Insulin Response A systematic review and meta-analysis. Diabetes Care June 2013 vol. 36 no. 6 1789-1796.

  10. Brandy A. Wicklow, Kristy D.M. Wittmeier, Andrea C. MacIntosh, Elizabeth A.C. Sellers, Lawrence Ryner, Hacene Serrai, Heather J. Dean, and Jonathan M. McGavock. Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents. Diabetes Care April 2012 35:4 905-910.

  11. Satoru Kodama, Kazumi Saito, Yoko Yachi, Mihoko Asumi, Ayumi Sugawara, Kumiko Totsuka, Aki Saito, and Hirohito Sone Association Between Serum Uric Acid and Development of Type 2 Diabetes Diabetes Care September 2009 32:9 1737-1742.

  12. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996;45:1119-1124.

  13. Pengcheng Xun, MD, PHD1, Kiang Liu, PHD3, Wenhong Cao, MD, Stephen Sidney, MD, MPH, O. Dale Williams, PHD and Ka He, MD, SCD Fasting Insulin Level Is Positively Associated With Incidence of Hypertension Among American Young Adults A 20- year follow-up study. Diabetes Care July 2012 35:7 1532-1537.

  14. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846.

  15. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996;45:1119-1124.

  16. Perfi l de salud de los trabajadores del Instituto Mexicano del Seguro Social. María Eugenia Velasco- Contreras. Rev Med Inst Mex Seguro Soc. 2013;51 (1):12-25.

  17. Steven M. Haffner, MD. Epidemiology of Type 2 Diabetes: Risk Factors Diabetes Care December 1998 vol. 21 no. Supplement 3 C3-C6.

  18. Global status report on noncommunicable diseases. Geneva, World Health Organization, 2013.

  19. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006, 3(11):e442.

  20. Defi nition, diagnosis and classifi cation of diabetes mellitus and its complications. Part 1: Diagnosis and classifi cation of diabetes mellitus. Geneva, World Health Organization, 1999 (WHO/NCD/NCS/99.2).

  21. Mauricio Hernández Ávila. Juan Pablo Gutiérrez ENSANUT 2012: revista Salud Pública de México. Secretaría de Salud, Subsecretaría de Prevención y Promoción de la Salud; Dirección General de Epidemiología, Manual de Procedimientos Estandarizados para la Vigilancia Epidemiológica de la Diabetes Mellitus tipo 2.

  22. Rosibel de los Ángeles Rodríguez Bolaños,1 Luz Myriam Reynales Shigematsu,1 Jorge Alberto Jiménez Ruíz,1 Sergio Arturo Juárez Márquez 2 y Mauricio Hernández Ávila 3 4. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2 en México: análisis de microcosteo . Rev Panam Salud Publica 28(6), 2010.

  23. Herman WH, Eastman RC. The effects of treatment on the direct costs of diabetes. Diabetes Care 21 Supply 3: C19-C24, 1998.

  24. Reduction in the incidencia of type 2 diabetes with lifestile intervention or metformin. Diabetes Prevention Program. N Engl J Med, Vol. 346, No. 6 February 7, 2002.

  25. UK Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352 : 854-865, 1998.

  26. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes. UKPDS 40. UK Prospective Diabetes Study Group. BMJ 317:720-726, 1998.

  27. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703-713,1998.

  28. Hobbs FD1. Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control. Int J Cardiol. 2006 Jun 16;110(2):137-45. Epub 2005 Nov 11.

  29. Nesto RW1.Gordon C. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome Am J Cardiovasc Drugs. 2005;5(6):379-87.

  30. Guías Técnicas de los Programas Integrados de Salud del Niño, Adolescente, Hombre, de la Mujer y del Adulto Mayor. IMSS, Agosto de 2006.

  31. Resultado de la Detección de Diabetes Mellitus e Hipertensión Arterial en los Servicios de Medicina Preventiva de Unidades médicas de medicina familiar a 36 años de operación. Velasco Contreras Maria Eugenia1 Grajales Muñiz Concepción2, Gutiérrez García José Natalio3 Gutiérrez Trujillo Gonzalo4 División de Planeación y Evaluación de los Programas Integrados de Salud1, División De Epidemiología Coordinación De Programas Integrados De Salud2, Coordinación De Salud Pública de la Delegación D. F3. Sur, 3 Titular de la Unidad de Salud Pública4

  32. Análisis del registro de seguimiento de pacientes con Resultado anormal de la DOD en la UMF N° 31, Delegación 4 Sur-Este del D.F. Dr. Juan Gilberto Alvarez de la O Director; Dr. Alfonso Vallejos Parás Médico Epidemiólogo MC; Jefe de Enfermeras Emigdio Martinez Antonio. Enfermera General Cynthia Nallely Valladolid Marín. Dra. Maria Eugenia Velasco Contreras Coordinadora médica de programas CPIS, División de Prevención de Enfermedades; Julio-Noviembre 2013

  33. Recuperación y Análisis del Censo de Pacientes con Diabetes mellitus; UMF N° 31, Delegación 4 Sur-Este del D.F. Dr. Juan Gilberto Alvarez de la O Director; Dr. Alfonso Vallejos Parás Médico Epidemiólogo MC; Lic. Isaura Lázaro Sánchez Jefe de ARIMAC; Dra. Maria Eugenia Velasco Contreras Coordinadora médica de programas CPIS División de Prevención de Enfermedades; Julio-Noviembre de 2013

  34. Margot González León, José Esteban Fernández Gárate, Irina Tatiana Hernández Cuesta, Nancy Minerva Torres Rojas, Nelly Cisneros González, Ramón Alberto Rascón Pacheco, Víctor Hugo Borja Aburto, Santiago Echevarría Zuno. La carga de las enfermedades en el IMSS, 2010. INSTITUTO MEXICANO DEL SEGURO SOCIAL DIRECCIÓN DE PRESTACIONES MÉDICAS Publicación 2012.

  35. Karin B. Michels, Caren G. Solomon, Frank B. Hu, Bernard A. Rosner, Susan E. Hankinson, Graham A. Colditz, and JoAnn E. Manson Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses’ Health Study. Diabetes Care June 2003 26:6 1752-1758.

  36. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17 Suppl 2:1-53.

  37. Cartera de alimentación correcta y actividad física. Dirección de Prestaciones Médicas; IMSS, 2014.




2020     |     www.medigraphic.com